Jarrett Jennifer bought RCUS
October 6, 2025 · Form 4 insider transaction
Jarrett Jennifer bought 12,500 shares of Arcus Biosciences, Inc. at $1.23 per share, a transaction worth $15.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,500
Price
$1.23
Total value
$15.3K
InsiderJarrett Jennifer
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 6, 2025
Filing dateOctober 8, 2025
Shares owned after226,732
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.; Includes 863 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan.